(Q28609429)

3 February 2017

title

Relation of elevated serum alanine aminotransferase activity with iron and antioxidant levels in the United States (English)

1 reference

3 February 2017

1 reference

United States of America

1 reference

Constance E. Ruhl

1

1 reference

3 February 2017

James E. Everhart

series ordinal

2

1 reference

3 February 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

3 February 2017

1 reference

3 February 2017

volume

124

1 reference

3 February 2017

issue

7

1 reference

3 February 2017

page(s)

1821–1829

1 reference

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

3 February 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Steatohepatitis: a tale of two "hits"?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Nonalcoholic steatohepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Update on nonalcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Nonalcoholic steatohepatitis: An expanded clinical entity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Insulin resistance-associated hepatic iron overload.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Nonalcoholic steatohepatitis: an evolving diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Motion - all patients with NASH need to have a liver biopsy: arguments against the motion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Updated definitions of healthy ranges for serum alanine aminotransferase levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Non-alcoholic steatohepatitis: another disease of affluence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Hepatic iron and nonalcoholic fatty liver disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Chronic hepatitis C treated with phlebotomy alone: biochemical and histological outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Management of nonalcoholic steatohepatitis: an analytic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Nonalcoholic steatohepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

The pathology of hepatic iron overload: a free radical--mediated process?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Hepatic mitochondrial energy production in rats with chronic iron overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Enhanced hepatic collagen type I mRNA expression into fat-storing cells in a rodent model of hemochromatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

Venesection therapy of insulin resistance-associated hepatic iron overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900395-0

10.1016/S0016-5085(03)00395-0

7 January 2021

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017